AEterna Zentaris Inc (ET82)

0.193 0.000 (0.00%)
Closed EUR Disclaimer

AEterna Zentaris Inc Company Profile

Industry
Biotechnology
Sector
Healthcare
Employees
12
Equity Type
ORD
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson’s disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Contact Information
Address
Summerville,29486 United States
Phone
843 900 3223
Fax
-
Top Executives
Name
Age
Since
Title
Gilles R. Gagnon 67 2007 Independent Director
Dennis Turpin 0 1999 Independent Director
Jacques Gauthier 59 2004 Director of Atrium Biotechnologies Inc
Ulf R. Rapp 0 0000 Member of the Scientific Advisory Board
Klaus Paulini 0 2019 President, CEO & Executive Director
Daniel Douglas Von Hoff 73 2005 Member of the Scientific Advisory Board
René Frydman 0 0000 Member of the Scientific Advisory Board
Alan H. DeCherney 0 0000 Member of the Scientific Advisory Board
Frans M. J. Debruyne 0 0000 Member of the Scientific Advisory Board
Klaus H. R. Diedrich 0 0000 Member of the Scientific Advisory Board
Peter G. Edwards 60 2020 Independent Director
Marcel Verheij 0 0000 Member of the Scientific Advisory Board
Gerald Batist 0 0000 Member of the Scientific Advisory Board
Hartmut Michel 0 0000 Member of the Scientific Advisory Board
Carolyn S. Egbert 0 2012 Independent Chair of the Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.